So far, the only mutation in the PRKD1 gene found for breast cancer does not explain the loss of its expression[24], and it is conceivable that downregulation of PKD1 expression is due to epigenetic modifications such as DNA methylation of its promoter[25]. This evidence concerns the gene PRKD1 and breast cancer.